Fulvestrant Injection 250 Mg

Product Name: Fulvestrant Injection 5 ML
Brand Name: Fulveser
Strength: 250 MG/  5 ML
Packing: Single PFS Per Box

Fulvestrant injection, available in 5 mL vials, is a medication primarily used to treat hormone receptor-positive metastatic breast cancer. Here's a brief description with pointers:

1. Purpose: Fulvestrant is utilized for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women who have not responded to other hormone therapies.

2. Administration: Administered via intramuscular injection by healthcare professionals in a clinical setting.

3. Mechanism of Action: Fulvestrant is a selective estrogen receptor degrader (SERD) that binds to and blocks estrogen receptors, inhibiting estrogen signaling and slowing cancer growth.

4. Indications: Used as a monotherapy or in combination with other treatments for hormone receptor-positive metastatic breast cancer.

5. Dosage: The standard dosage is 500 mg administered as two 5 mL injections on days 1, 15, and 29, followed by monthly maintenance doses.

6. Side Effects: Common side effects may include injection site reactions, hot flashes, nausea, fatigue, and musculoskeletal pain. Rarely, allergic reactions or liver toxicity may occur.

7. Contraindications: Avoid use in patients with a known hypersensitivity to fulvestrant or any components of the formulation.

8. Precautions: Fulvestrant should be used cautiously in patients with liver impairment, as it may cause hepatotoxicity. Regular liver function tests are recommended during treatment.

9. Storage: Store fulvestrant injection vials according to manufacturer instructions, typically at controlled room temperature and protected from light.

10. Patient Monitoring: Regular monitoring of liver function, blood counts, and disease progression is necessary during treatment to assess for potential adverse effects and treatment response.

11. Education: Patients should be educated on the purpose of the medication, potential side effects, and the importance of adherence to the prescribed dosage regimen.

12. Follow-Up: Close follow-up with healthcare providers is essential to monitor treatment response, manage side effects, and adjust the treatment plan as needed.